1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Patholigists reductions next

Discussion in 'American Pathology Partners' started by Anonymous, Aug 9, 2013 at 11:11 PM.

  1. Anonymous

    Anonymous Guest

    Bend over doc's. we need to shed half of your positions and bring on new docs at half the salary.

    Hogs are going to get slaughtered.
     
  2. Anonymous

    Anonymous Guest

    working on a 20% pay reduction